Euroapi SAS

PA:EAPI France Drug Manufacturers - Specialty & Generic
Market Cap
$124.32 Million
€121.11 Million EUR
Market Cap Rank
#19955 Global
#139 in France
Share Price
€1.27
Change (1 day)
+1.11%
52-Week Range
€1.26 - €3.46
All Time High
€18.72
About

Euroapi S.A. develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use in France, Europe, Rest of Europe, North America, the Asia Pacific, and internationally. The company offers contract development manufacturing organization for different classes of tides that uses solid phase chemistry;… Read more

Euroapi SAS (EAPI) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: 0.018x

Based on the latest financial reports, Euroapi SAS (EAPI) has a cash flow conversion efficiency ratio of 0.018x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€17.10 Million) by net assets (€953.40 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Euroapi SAS - Cash Flow Conversion Efficiency Trend (2019–2024)

This chart illustrates how Euroapi SAS's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Euroapi SAS Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Euroapi SAS ranked by their cash flow conversion efficiency.

Annual Cash Flow Conversion Efficiency for Euroapi SAS (2019–2024)

The table below shows the annual cash flow conversion efficiency of Euroapi SAS from 2019 to 2024.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 €983.50 Million €122.90 Million 0.125x +2173.08%
2023-12-31 €927.70 Million €5.10 Million 0.005x -86.38%
2022-12-31 €1.11 Billion €44.80 Million 0.040x -42.91%
2021-12-31 €1.01 Billion €71.50 Million 0.071x -27.75%
2020-12-31 €989.40 Million €96.80 Million 0.098x +185.41%
2019-12-31 €1.02 Billion €34.90 Million 0.034x --